1. Cell Mol Gastroenterol Hepatol. 2023;16(5):757-782. doi: 
10.1016/j.jcmgh.2023.07.008. Epub 2023 Jul 22.

Deciphering Brain Metastasis Stem Cell Properties From Colorectal Cancer 
Highlights Specific Stemness Signature and Shared Molecular Features.

Desette A(1), Guichet PO(2), Emambux S(3), Masliantsev K(2), Cortes U(2), Ndiaye 
B(2), Milin S(4), George S(5), Faigner M(6), Tisserand J(7), Gaillard A(8), Brot 
S(8), Wager M(9), Tougeron D(10), Karayan-Tapon L(2).

Author information:
(1)Université de Poitiers, CHU Poitiers, ProDiCeT, UR 24144, Poitiers, France; 
Laboratoire de Cancérologie Biologique, CHU de Poitiers, Poitiers, France. 
Electronic address: amandine.desette@univ-poitiers.fr.
(2)Université de Poitiers, CHU Poitiers, ProDiCeT, UR 24144, Poitiers, France; 
Laboratoire de Cancérologie Biologique, CHU de Poitiers, Poitiers, France.
(3)Université de Poitiers, CHU Poitiers, ProDiCeT, UR 24144, Poitiers, France; 
Service d'oncologie médicale, CHU de Poitiers, Poitiers, France.
(4)Université de Poitiers, CHU Poitiers, ProDiCeT, UR 24144, Poitiers, France; 
Service d'Anatomie et de Cytologie Pathologiques, CHU de Poitiers, Poitiers, 
France.
(5)MGX-Montpellier GenomiX, Université de Montpellier, CNRS, INSERM, 
Montpellier, France.
(6)Service d'oncologie médicale, CHU de Poitiers, Poitiers, France.
(7)Pôle gériatrique, CHU de Poitiers, Poitiers, France.
(8)Université de Poitiers, CHU de Poitiers, INSERM, LNEC, Poitiers, France.
(9)Université de Poitiers, CHU Poitiers, ProDiCeT, UR 24144, Poitiers, France; 
Service de Neurochirurgie, CHU de Poitiers, Poitiers, France.
(10)Université de Poitiers, CHU Poitiers, ProDiCeT, UR 24144, Poitiers, France; 
Service d'hépato-gastro-entérologie, CHU de Poitiers, Poitiers, France.

BACKGROUND & AIMS: Brain metastases (BMs) from colorectal cancer (CRC) are 
associated with significant morbidity and mortality, with chemoresistance and 
short overall survival. Migrating cancer stem cells with the ability to initiate 
BM have been described in breast and lung cancers. In this study, we describe 
the identification and characterization of cancer stem cells in BM from CRC.
METHODS: Four brain metastasis stem cell lines from patients with colorectal 
cancer (BM-SC-CRC1 to BM-SC-CRC4) were obtained by mechanical dissociation of 
patient's tumors and selection of cancer stem cells by appropriate culture 
conditions. BM-SC-CRCs were characterized in vitro by clonogenic and 
limiting-dilution assays, as well as immunofluorescence and Western blot 
analyses. In ovo, a chicken chorioallantoic membrane (CAM) model and in vivo, 
xenograft experiments using BALB/c-nude mice were realized. Finally, a whole 
exome and RNA sequencing analyses were performed.
RESULTS: BM-SC-CRC formed metaspheres and contained tumor-initiating cells with 
self-renewal properties. They expressed stem cell surface markers (CD44v6, CD44, 
and EpCAM) in serum-free medium and CRC markers (CK19, CK20 and CDX-2) in fetal 
bovine serum-enriched medium. The CAM model demonstrated their invasive and 
migratory capabilities. Moreover, mice intracranial xenotransplantation of 
BM-SC-CRCs adequately recapitulated the original patient BM phenotype. Finally, 
transcriptomic and genomic approaches showed a significant enrichment of 
invasiveness and specific stemness signatures and highlighted KMT2C as a 
potential candidate gene to potentially identify high-risk CRC patients.
CONCLUSIONS: This original study represents the first step in CRC BM initiation 
and progression comprehension, and further investigation could open the way to 
new therapeutics avenues to improve patient prognosis.

Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.

DOI: 10.1016/j.jcmgh.2023.07.008
PMCID: PMC10520365
PMID: 37482243 [Indexed for MEDLINE]